Literature DB >> 9925126

Vitamin K intake and hip fractures in women: a prospective study.

D Feskanich1, P Weber, W C Willett, H Rockett, S L Booth, G A Colditz.   

Abstract

BACKGROUND: Vitamin K mediates the gamma-carboxylation of glutamyl residues on several bone proteins, notably osteocalcin. High serum concentrations of undercarboxylated osteocalcin and low serum concentrations of vitamin K are associated with lower bone mineral density and increased risk of hip fracture. However, data are limited on the effects of dietary vitamin K.
OBJECTIVE: We investigated the hypothesis that high intakes of vitamin K are associated with a lower risk of hip fracture in women.
DESIGN: We conducted a prospective analysis within the Nurses' Health Study cohort. Diet was assessed in 72327 women aged 38-63 y with a food-frequency questionnaire in 1984 (baseline). During the subsequent 10 y of follow-up, 270 hip fractures resulting from low or moderate trauma were reported.
RESULTS: Women in quintiles 2-5 of vitamin K intake had a significantly lower age-adjusted relative risk (RR: 0.70; 95% CI: 0.53, 0.93) of hip fracture than women in the lowest quintile (< 109 microg/d). Risk did not decrease between quintiles 2 and 5 and risk estimates were not altered when other risk factors for osteoporosis, including calcium and vitamin D intakes, were added to the models. Risk of hip fracture was also inversely associated with lettuce consumption (RR: 0.55; 95% CI: 0.40, 0.78) for one or more servings per day compared with one or fewer servings per week), the food that contributed the most to dietary vitamin K intakes.
CONCLUSIONS: Low intakes of vitamin K may increase the risk of hip fracture in women. The data support the suggestion for a reassessment of the vitamin K requirements that are based on bone health and blood coagulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9925126     DOI: 10.1093/ajcn/69.1.74

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  70 in total

Review 1.  The role of vitamins in cystic fibrosis.

Authors:  S B Carr; J McBratney
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

2.  Association of dietary and biochemical measures of vitamin K with quantitative ultrasound of the heel in men and women.

Authors:  R R McLean; S L Booth; D P Kiel; K E Broe; D R Gagnon; K L Tucker; L A Cupples; M T Hannan
Journal:  Osteoporos Int       Date:  2006-01-06       Impact factor: 4.507

3.  Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials.

Authors:  Yanfu Fang; Chuanlai Hu; Xingyong Tao; Yuhui Wan; Fangbiao Tao
Journal:  J Bone Miner Metab       Date:  2011-06-15       Impact factor: 2.626

Review 4.  Gene expression studies of osteoporosis: implications for microarray research.

Authors:  V Dvornyk; R R Recker; H-W Deng
Journal:  Osteoporos Int       Date:  2003-04-29       Impact factor: 4.507

Review 5.  Osteoporosis prevention and nutrition.

Authors:  Katherine L Tucker
Journal:  Curr Osteoporos Rep       Date:  2009-12       Impact factor: 5.096

6.  High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease.

Authors:  A Kuwabara; K Tanaka; N Tsugawa; H Nakase; H Tsuji; K Shide; M Kamao; T Chiba; N Inagaki; T Okano; S Kido
Journal:  Osteoporos Int       Date:  2008-09-30       Impact factor: 4.507

Review 7.  Skeletal effects of nutrients and nutraceuticals, beyond calcium and vitamin D.

Authors:  J W Nieves
Journal:  Osteoporos Int       Date:  2012-11-14       Impact factor: 4.507

8.  Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial.

Authors:  N Emaus; C G Gjesdal; B Almås; M Christensen; A S Grimsgaard; G K R Berntsen; L Salomonsen; V Fønnebø
Journal:  Osteoporos Int       Date:  2009-11-25       Impact factor: 4.507

Review 9.  Bone health. New role for vitamin K?

Authors:  Milly Ryan-Harshman; Walid Aldoori
Journal:  Can Fam Physician       Date:  2004-07       Impact factor: 3.275

10.  Prior treatment with vitamin K(2) significantly improves the efficacy of risedronate.

Authors:  Y Matsumoto; Y Mikuni-Takagaki; Y Kozai; K Miyagawa; K Naruse; H Wakao; R Kawamata; I Kashima; T Sakurai
Journal:  Osteoporos Int       Date:  2009-03-12       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.